Discover Enlicitide, a new daily pill for genetic high cholesterol (HeFH). A recent trial shows it lowers bad LDL cholesterol ...

Scribe Therapeutics highlights data underpinning its comprehensive strategy targeting key lipid drivers of ASCVD at AHA Scientific Sessions 2025 ...

The drug enlicitide reduced cholesterol for adults with high levels due to an inherited disorder and may also work for a broader population.

A cholesterol-lowering regimen that combines PCSK9 inhibitor alirocumab with statin therapy safely reduced low-density lipoprotein cholesterol (LDL-C) levels by more than 50% in adults early after ...

WASHINGTON -- Daily treatment with the novel drug saroglitazar significantly reduced liver fat in women with metabolic ...

1 School of Pharmacy, Hubei University of Science and Technology, Xianning, China 2 Hubei Key Laboratory of Diabetes and Angiopathy, Hubei University of Science and Technology, Xianning, China The low ...

Background The lectin-like oxidised low-density lipoprotein receptor-1 (LOX-1) mediates atherosclerotic plaque inflammation and vulnerability. On activation, LOX-1 sheds its extracellular domain into ...

Nearly 1 in 3 Americans has high cholesterol, elevating their risk of heart attack and stroke. While statins remain the gold standard for managing cholesterol, many people turn to natural remedies ...

The brain’s cerebellum plays a key role in coordinating movement, balance, and cognition. Injury to the cerebellum can have a profound impact on basic motor skills, such as sitting, standing, and ...

Introduction: Adventitial fibroblasts play an important role in maintaining vascular homeostasis but their functions in atherogenesis remain elusive. IκB kinase β (IKKβ), a central coordinator of ...

An investigational drug, currently known as AZD0780, lowers low-density-lipoprotein cholesterol (LDL-C) to target levels in most patients whose cholesterol is still over target despite statin therapy, ...